Stockreport

Eli Lilly's oral GLP-1RA maintains weight loss from injectable drugs [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF During the 52-week Phase III ATTAIN-MAINTAIN study (NCT06584916), the weight loss pill offered significant weight maintenance benefits over placebo when used as an adju [Read more]